skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus

(2086) Views  (544) Full article downloads

Authors: WH Wilson Tang

Published Date November 2007 Volume 2007:3(5) Pages 639 - 645
DOI: http://dx.doi.org/10.2147/VHRM.S

WH Wilson Tang

Section of Heart Failure and Cardiac Transplantation Medicine, Department of Cardiovascular Medicine, the Cleveland Clinic, Cleveland, OH, USA

Abstract: Anti-adrenergic therapy has been widely accepted as an important therapeutic intervention in patients with chronic heart failure. However, there has been continuing controversy regarding the risks and clinical significance of metabolic effects of different anti-adrenergic drugs. This review summarizes what has been learned from clinical trial evidence regarding the benefits of anti-adrenergic drugs in diabetic patients with chronic heart failure.

Keywords: diabetes mellitus, congestive heart failure, anti-adrenergic drugs, carvedilol








Readers of this article also read:

Emergency endovascular repair of acute descending thoracic aortic dissection
Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function
Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia)
Are pleiotropic effects of statins real?
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Erratum
A case of recurrent bloody tears
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University